Frequent methylation of estrogen receptor in prostate cancer: Correlation with tumor progression

Cancer Research

Volumn 60, Issue 3, 2000, Pages 702-706

  Li, Long Cheng ^a   Chui, Richard ^a   Nakajima, Koichi ^a   Oh, Bong Ryoul ^a   Au, Harry C ^a   Dahiya, Rajvir ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Urology Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE; ESTROGEN RECEPTOR;

ARTICLE; CHROMOSOME 6Q; GENE SEQUENCE; HUMAN; HUMAN CELL; METHYLATION; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; TUMOR GROWTH;

DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; HUMANS; MALE; PROSTATIC NEOPLASMS; RECEPTORS, ESTROGEN; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0033950894     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Cox, R. L., and Crawford, E. D. Estrogens in the treatment of prostate cancer. J. Urol., 154: 1991-1998, 1995.
2. Mangan, F. R., Neal, G. E., and Williams, D. C. The effects of diethylstilboestrol and castration on the nucleic acid and protein metabolism of rat prostate gland. Biochem. J., 104: 1075-1081, 1967.
3. Castagnetta, L. A., and Carruba, G. Human prostate cancer: a direct role for oestrogens. Ciba Found. Symp., 191: 269-286, 1995.
4. Carruba, G., Miceli, M. D., Comito, L., Farruggio, R., Sorci, C. M., Oliveri, G., Amodio, R., di Falco, M., d'Amico, D., and Castagnetta, L. A. Multiple estrogen function in human prostate cancer cells. Ann. N Y Acad. Sci., 784: 70-84, 1996.
5. Brolin, J., Skoog, L., and Ekman, P. Immunohistochemistiy and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue. Prostate, 20: 281-295, 1992.
6. Mobbs, B. G., Johnson, I. E., and Liu, Y. Quantitation of cytosolic and nuclear estrogen and progesterone receptor in benign, untreated, and treated malignant human prostatic tissue by radioligand binding and enzyme-immunoassays. Prostate, 16: 235-244, 1990.
7. Castagnetta, L. A., Miceli, M. D., Sorci, C. M., Pfeffer, U., Farruggio, R., Oliveri, G., Calabro, M., and Carruba, G. Growth of LNCaP human prostate cancer cells is stimulated by estradiol via its own receptor. Endocrinology, 136: 2309-2319, 1995.
8. Carruba, G., Pfeffer, U., Fecarotta, E., Coviello, D. A., D'Amato, E., Lo Castro, M., Vidali, G., and Castagnetta, L. Estradiol inhibits growth of hormone-nonresponsive PC3 human prostate cancer cells. Cancer Res., 54: 1190-1193, 1994.
9. Menasce, L. P., White, G. R., Harrison, C. J., and Boyle, J. M. Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique. Genomics, 17: 263-265, 1993.
10. Evans, R. M. The steroid and thyroid hormone receptor superfamily. Science (Washington DC), 240: 889-895, 1988.
11. Hobisch, A., Hittmair, A., Daxenbichler, G., Wille, S., Radmayr, C., Hobisch-Hagen, P., Bartsch, G., Klocker, H., and Culig, Z. Metastatic lesions from prostate cancer do not express oestrogen and progesterone receptors (see comments). J. Pathol., 182: 356-361, 1997.
12. Sonnenschein, C., Olea, N., Pasanen, M. E., and Soto, A. M. Negative controls of cell proliferation: human prostate cancer cells and androgens. Cancer Res., 49: 3474-3481, 1989.
13. Nativ, O., Umehara, T., Colvard, D. S., Therneau, T. M., Farrow, G. M., Spelsberg, T. C., and Lieber, M. M. Relationship between DNA ploidy and functional estrogen receptors in operable prostate cancer. Eur. Urol., 32: 96-99, 1997.
14. Konishi, N., Nakaoka, S., Hiasa, Y., Kitahori, Y., Ohshima, M., Samma, S., and Okajima, E. Immunohistochemical evaluation of estrogen receptor status in benign prostatic hypertrophy and in prostate carcinoma and the relationship to efficacy of endocrine therapy. Oncology, 50: 259-263, 1993.
15. Ekman, P., Snochowski, M., Dahlberg, E., Bression, D., Hogberg, B., and Gustafsson, J. A. Steroid receptor content in cytosol from normal and hyperplastic human prostates. J. Clin. Endocrinol. Metab., 49: 205-215, 1979.
16. Bird, A. P. CpG-rich islands and the function of DNA methylation. Nature (Lond.), 321: 209-213, 1986.
17. Vertino, P. M., Yen, R. W., Gao, J., and Baylin, S. B. De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-S-)-methyl-transferase. Mol. Cell. Biol., 16: 4555-4565, 1996.
18. Wu, J., Issa, J. P., Herman, J., Bassett, D. E., Jr., Nelkin, B. D., and Baylin, S. B. Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells (see comments). Proc. Natl. Acad. Sci. USA, 90: 8891-8895, 1993.
19. Ottaviano, Y. L., Issa, J. P., Parl, F. F., Smith, H. S., Baylin, S. B., and Davidson, N. E. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res., 54: 2552-2555, 1994.
20. Issa, J. P., Ottaviano, Y. L., Celano, P., Hamilton, S. R., Davidson, N. E., and Baylin, S. B. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat. Genet., 7: 536-540, 1994.
21. Issa, J. P., Baylin, S. B., and Belinsky, S. A. Methylation of the estrogen receptor CpG island in lung tumors is related to the specific type of carcinogen exposure. Cancer Res., 56: 3655-3658, 1996.
22. Narayan, P., and Dahiya, R. Establishment and characterization of a human primary prostatic adenocarcinoma cell line (ND-1). J. Urol., 148: 1600-1604, 1992.
23. Hayward, S. W., Dahiya, R., Cunha, G. R., Bartek, J., Deshpande, N., and Narayan, P. Establishment and characterization of an immortalized but non- transformed human prostate epithelial cell line: BPH-1. In Vitro Cell. Dev. Biol. Anim. 31: 14-24, 1995.
24. Dahiya, R., Lee, C., Zhu, Z., and Thompson, H. J. Microsatellite instability in an animal model of mammary carcinogenesis. Int. J. Oncol., 13: 23-28, 1998.
25. Clark, S. J., Harrison, J., Paul, C. L., and Frommer, M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res., 22: 2990-2997, 1994.
26. Paul, C. L., and Clark, S. J. Cytosine methylation: quantitation by automated genomic sequencing and GENESCAN analysis. Biotechniques, 21: 126-133, 1996.
27. Cordon-Cardo, C., Koff, A., Drobnjak, M., Capodieci, P., Osman, I., Millard, S. S., Gaudin, P. B., Fazzari, M., Zhang, Z. F., Massague, J., and Scher, H. I. Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma (see comments). J. Natl. Cancer Inst., 90: 1284-1291, 1998.
28. Bird, A. The essentials of DNA methylation. Cell, 70: 5-8, 1992.
29. Mohandas, T., Sparkes, R. S., and Shapiro, L. J. Reactivation of an inactive human X chromosome: evidence for X inactivation by DNA methylation. Science (Washington DC), 211: 393-396, 1981.
30. Li, E., Beard, C., Forster, A. C., Bestor, T. H., and Jaenisch, R. DNA methylation, genomic imprinting, and mammalian development. Cold Spring Harb. Symp. Quant. Biol., 58: 297-305, 1993.
31. Baylin, S. B., Makos, M., Wu, J. J., Yen, R. W., de Bustros, A., Vertino, P., and Nelkin, B. D. Abnormal patterns of DNA methylation in human neoplasia: potential consequences for tumor progression. Cancer Cells, 3: 383-390, 1991.
32. Farnsworth, W. E. Roles of estrogen and SHBG in prostate physiology. Prostate, 28: 17-23, 1996.
33. el-Deiry, W. S., Nelkin, B. D., Celano, P., Yen, R. W., Falco, J. P., Hamilton, S. R., and Baylin, S. B. High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. Proc. Natl. Acad. Sci. USA, 88: 3470-3474, 1991.
34. Belinsky, S. A., Nikula, K. J., Baylin, S. B., and Issa, J. P. Increased cytosine DNA-methyltransferase activity is target-cell- specific and an early event in lung cancer. Proc. Natl. Acad. Sci. USA, 93: 4045-4050, 1996.
35. Szyf, M. DNA methylation properties: consequences for pharmacology. Trends Pharmacol. Sci., 15: 233-238, 1994.
36. Szyf, M. The DNA methylation machinery as a target for anticancer therapy. Pharmacol. Ther., 70: 1-37, 1996.